Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use

INTRODUCTION: Hypoxic tumor microenvironment (TME) is the major contributor to cancer metastasis, resistance to chemotherapy, and recurrence of tumors. So far, no approved treatment has been available to overcome tumor hypoxia. OBJECTIVES: The present study aimed to relieve tumor hypoxia via a nanoz...

Descripción completa

Detalles Bibliográficos
Autores principales: Veroniaina, Hanitrarimalala, Wu, Zhenghong, Qi, Xiaole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463960/
https://www.ncbi.nlm.nih.gov/pubmed/34603790
http://dx.doi.org/10.1016/j.jare.2021.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463960/
https://www.ncbi.nlm.nih.gov/pubmed/34603790
http://dx.doi.org/10.1016/j.jare.2021.02.004

Ejemplares similares